Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Future Oncology (London, England)
|
June 19, 2023
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer
Thomas J Herzog, John L Hays, Joyce N Barlin, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor
Bryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2012
Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf
Daniel P Sutherlin, Stewart Baker, Angelina Bisconte, et al.
Journal of Medicinal Chemistry
|
May 26, 2012
Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition
Brian S Safina, Stewart Baker, Matt Baumgardner, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Future Oncology (London, England)
|
June 19, 2023
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer
Thomas J Herzog, John L Hays, Joyce N Barlin, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor
Bryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2012
Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf
Daniel P Sutherlin, Stewart Baker, Angelina Bisconte, et al.
Journal of Medicinal Chemistry
|
May 26, 2012
Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition
Brian S Safina, Stewart Baker, Matt Baumgardner, et al.
Page
of 6